If you plan to ask a question, please use the following link: Inspire's Q2 2024 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call. Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the ...

MINNEAPOLIS, July 02, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2024 after the close of trading on Tuesday, August 6. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event an ...

A month has gone by since the last earnings report for Inspire Medical Systems (INSP) . Shares have lost about 7.3% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Inspire due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. Inspire Medical Q1 Earnings Beat, Gross Mar ...

MINNEAPOLIS, June 04, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Truist Securities Medtech Conference on Tuesday, June 18, 2024. Inspire is scheduled to present at 10:40 a.m. Eastern Time. The presentation will be accessible via a live webcast here. A ...

Inspire Medical Systems, Inc. (INSP) is well-poised for growth in the coming quarters, courtesy of its focus on research and development (R&D). The optimism led by a solid first-quarter 2024 performance and its global presence are expected to contribute further. However, concerns regarding overdependence on the Inspire system and a competitive landscape prevail. Over the past year, this Zacks Rank #3 (Hold) stock has lost 49.3% compared with the 25.3% decline of the industry. The S&P 500 has witnessed 26.7% ...

Inspire Medical Systems, Inc. (INSP) delivered a loss per share of 34 cents in first-quarter 2024, narrower than the year-ago period’s loss of 53 cents per share. The metric was also narrower than the Zacks Consensus Estimate of a loss of 63 cents per share.Revenues in DetailInspire Medical registered revenues of $164 million in the first quarter, up 28.2% year over year. The figure beat the Zacks Consensus Estimate by 1.5%.Per management, the top-line growth was driven by increased market penetration in ex ...

For the quarter ended March 2024, Inspire Medical Systems (INSP) reported revenue of $164.01 million, up 28.2% over the same period last year. EPS came in at -$0.34, compared to -$0.53 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $161.63 million, representing a surprise of +1.47%. The company delivered an EPS surprise of +46.03%, with the consensus EPS estimate being -$0.63.While investors scrutinize revenue and earnings changes year-over-year and how they compare ...

Inspire Medical Systems, Inc. (NYSE:INSP) Q1 2024 Results Conference Call May 7, 2024 5:00 PM ET Company Participants Ezgi Yagci - VP, IR Tim Herbert - Chairman and CEO Rick Buchholz - CFO Conference Call Participants Danielle Antalffy - UBS Travis Steed - Bank of America Adam Maeder - Piper Sandler Kallum Titchmarsh - Morgan Stanley David Rescott - Baird Anthony Petrone - Mizuho Chris Pasquale - Nephron Richard Newitter - Truist Securities Shagun Singh - RBC John Block - Stifel Mike Kratky - Leerink Partne ...

Inspire Medical Systems (INSP) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.63. This compares to loss of $0.53 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 46.03%. A quarter ago, it was expected that this maker of devices for treating obstructive sleep apnea would post a loss of $0.04 per share when it actually produced earnings of $0.49, delivering a surprise of 1,32 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 10-Q ________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38468 ______________________________ Inspire ...